Why Your Pharmacy Spend is a “Black Box” and How to Fix the Variance

For most CFOs and CHROs, annual decisions regarding healthcare benefit renewals feel less like a strategic financial exercise and more like a high-stakes guessing game. While almost every other line item in a corporate budget is scrutinized for predictability and market alignment, pharmacy spend remains an elusive, unmanaged cost for most businesses. 

It is a volatile, opaque ‘black box’ that frequently forces finance teams into a defensive posture, resulting in the annual inevitability of budget padding just to provide coverage quarter by quarter. In 2026, pharmacy spend is approaching roughly one-third of total healthcare costs and stands as the fastest-growing expense for employers. The cost of guesswork has become unsustainable.

CFOs and finance teams deserve a seat at the table when it comes to benefits decisions. When finance leaders are made co-pilots of selection, they’re able to lend much-needed financial integrity during contract negotiations and ultimately repair the broken budgeting of pharmacy benefits. 

Pharmacy Benefits Black Box & Budget Padding

The lack of predictability in spending most pharmacy benefit managers (PBMs) provide has created unplanned variance CFOs absorb year over year. Many finance teams (45% of CFOs) build conservatism into their healthcare budgets simply because costs are difficult to predict. This unpredictability cannot be overstated: over two-thirds (72%) of CFOs report that healthcare expenses are more difficult to predict than any other major business expense.

This is the definition of absorbing the risk of working with the wrong PBM. If your team cannot trace cost drivers back to specific claims, you’re essentially flying blind. This opacity is often a byproduct of how contracts are structured. Legacy and so-called ‘pass-through’ PBM contracts frequently lock in misaligned incentives; this results in their ability to conduct spread pricing and rebate retention, making it nearly impossible to see where your money is actually going and if they’re using it effectively. 

To fix this, organizations must shift from blindly trusting in legacy systems and vendor claims to modern PBMs who can deliver claim-level transparency and a pricing model that can be audited for benefit sustainability.

Fixing the Variance of Pharmacy Spend

Breaking the Bundle to See Real Savings

The fundamental barrier to lower costs is often the PBM contract structure itself. Bundled arrangements, often within carrier-led plans, where the medical carrier also provides the PBM services, create a significant leverage problem for the employer. Because these services are tied together, your ability to negotiate specific pharmacy terms or audit high-cost claims is severely limited. 

By unbundling pharmacy from the medical carrier, self-insured employers regain the control necessary to see real savings. This strategic move alone often leads to 10% to 20% improvements by targeting the specific areas where costs are unnecessarily inflated. Unbundling transforms the pharmacy benefit from a passive expense into a managed financial asset.

From Reactivity to Proactive Forecasting

You would never dream of managing a corporate budget or a supply chain using six-month-old data, yet many organizations manage their healthcare spend using lagging reports provided by their pharmacy benefit managers. You simply cannot manage a modern budget with outdated information. Real-time claim data is the essential tool for moving from broad budget "guesstimates" to tight, defensible financial projections. 

When you have a clear view of the data as it happens, you move from reactive budget adjustments, where you are constantly explaining variances to the board, to proactive cost management. This visibility allows you to intervene before a single high-cost claim, like an unexpected specialty medication claim, materially impacts quarterly forecasts.

Preventing Runaway Spend on High-Cost Claims

Meaningful reductions to your pharmacy spend do not require broad, restrictive benefit cuts and ‘carve-outs’. In reality, it just takes a strategic approach to capturing the lowest net costs on traditionally ‘high-cost’ medications like specialty drugs. 

Pharmacy economics follows the 80/20 rule: a small percentage of your population using high-cost specialty therapies drives the vast majority of your budget. Instead of cutting benefits, the more effective strategy is to manage these claims with surgical precision. 

At SmithRx, we run these, and every claim, through our Drug Pathways Engine (DPE) to drive to the lowest net cost. The DPE evaluates each claim, identifies the optimal pathway, and routes it across drug selection, sourcing, and cost optimization levers to achieve the lowest net cost. We don’t stop at simply identifying these opportunities, we’ve built processes and teams to lead guided transitions to capture these savings.

A truly modern approach means that you can achieve millions in savings and maintain a high-quality benefit plan by simply managing the most expensive claims better, rather than penalizing the general member population.

Taking the Reins of Your Pharmacy Benefits

The shift toward transparency is about more than just reducing the total cost of care; it is about restoring forecasting confidence. CFOs who work hand-in-hand with benefits teams to demand visibility don’t need to pad their budgets for "what ifs" because they are in the driver’s seat of their pharmacy benefit plan. By unbundling your spend and utilizing real-time data, you can finally treat your pharmacy benefit like any other predictable, high-performing part of your business.

Want to bring predictability and competitive benefits to your business? Reach out to our team for a transparent audit of your current pharmacy spend to identify hidden variances and potential savings.